Prostate cancer is the most commonly diagnosed cancer in Australia, representing 33% of cancers in men and accounting for around 20,000 new cases diagnosed per year.
The E.J. Whitten Foundation Prostate Cancer Research Centre at Epworth explores better diagnosis and treatment options, giving patients the opportunity to be part of studies that may extend their lives. It also enables researchers and physicians to apply a tailored approach to the disease, so patients receive targeted treatments for better outcomes.
With your support, we can lead clinical trials and deliver innovative treatments such as Irreversible electroporation (IRE or NanoKnife) and provide hope for men with prostate cancer.